Keywords: Alexza Pharma, Adasuve, NDA re-submission, Agitation, Schizophrenia, USA, FDA

Alexza rockets on re-submission of Adasuve NDA

Article | 25 June 2012

Print This

USA-based Alexza Pharmaceuticals (Nasdaq: ALXA) saw its shares soar 44.9% to close at $3.97 on Friday, after the company said it has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in